What is STATKING Consulting?
STATKING Clinical Services operates as a comprehensive contract research organization, providing end-to-end support for pharmaceutical and medical device innovators. The firm specializes in navigating the complex regulatory and scientific requirements from initial target discovery through to Phase I-III clinical trials. Their core competencies include biostatistics, clinical data management, and medical writing, with a specialized focus on high-growth therapeutic areas such as oncology, central nervous system disorders, and orphan drug development. By integrating statistical consulting with clinical trial management, STATKING serves as a critical partner for organizations seeking to streamline the path from laboratory research to IND filing and commercialization.
How much funding has STATKING Consulting raised?
STATKING Consulting has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in STATKING Consulting
PPP
Public-Private Partnership
What's next for STATKING Consulting?
With this late-stage funding, STATKING Consulting is poised to scale its infrastructure to meet the increasing demand for specialized clinical trial management. The strategic allocation of these resources will likely focus on enhancing their technological stack for data management and expanding their expertise in biologics and medical device testing. As the CRO industry continues to consolidate, STATKING is strategically positioned to leverage its deep domain expertise to capture additional market share, potentially through the expansion of its global service delivery model and the deepening of its therapeutic-specific research capabilities. The firm remains a pivotal player in the life sciences ecosystem, facilitating the transition of complex therapies from development to patient access.
See full STATKING Consulting company page
